// App-Quantinova.ai

AB0158 (2018) : Histological and serological characteristics contribute to divergent outcomes for indigenous patients with lupus nephritis

Researchers

Presenter

  • J. Nossent

Principal Investigators

  • W. Raymond

  • A. Kang

  • M. Ognejovic

  • A. Chakera

  • D. Wong

Medical Centers

  • Sir Charles Gairdner Hospital, Perth, Australia

  • School of Medicine, University of Western Australia

  • Pathology, PathWest Laboratory Medicine, Nedlands

  • School of Medicine, University of Western Australia

  • Sir Charles Gairdner Hospital, Perth, Australia

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Nephrology

Disease

  • Lupus nephritis

  • Venous thrombosis

  • Nephritis

  • Lupus

Biomarkers

  • Immunoglobulin A

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A